Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Classical Hodgkin's Lymphoma”

228 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 228 results

Testing effectiveness (Phase 2)Study completedNCT00540007
What this trial is testing

Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Disease
Washington University School of Medicine 80
Large-scale testing (Phase 3)Active Not RecruitingNCT02661503
What this trial is testing

HD21 for Advanced Stages

Who this might be right for
Classical Hodgkin Lymphoma
University of Cologne 1,500
Not applicableStudy completedNCT04858568
What this trial is testing

Immune Responses to COVID-19 Vaccination in Lymphoma Patients

Who this might be right for
Classical Hodgkin LymphomaDiffuse Large B Cell LymphomaPrimary Mediastinal B Cell Lymphoma+10 more
University Hospital Southampton NHS Foundation Trust 592
Large-scale testing (Phase 3)Looking for participantsNCT06170489
What this trial is testing

A Phase III Clinical Study Comparing JS004 Plus Toripalimab With Investigator-Selected Chemotherapy in Patients With PD-(L)1monoclonal Antibody Refractory Classic Hodgkin Lymphoma (cHL)

Who this might be right for
Hodgkin Lymphoma
Shanghai Junshi Bioscience Co., Ltd. 185
Large-scale testing (Phase 3)UnknownNCT04342936
What this trial is testing

Study of Camrelizumab (SHR-1210) vs. Chemotherapy in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
Jiangsu HengRui Medicine Co., Ltd. 56
Post-approval studies (Phase 4)Looking for participantsNCT06831370
What this trial is testing

Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India

Who this might be right for
Hodgkin Lymphoma
Takeda 124
Not applicableUnknownNCT04419441
What this trial is testing

Immune Checkpoint Inhibitors and Radiotherapy in Relapsed/Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaImmune Checkpoint InhibitorRadiotherapy
Ospedale Maggiore Di Trieste 12
Not applicableStudy completedNCT06295211
What this trial is testing

Brentuximab Vedotin Combined With Bendamustine Supercharge, a Low-toxicity and Efficient Salvage Regimen for Primary Refractory or First-relapsed Classic Hodgkin Lymphoma: Long-term Results of a Retrospective Monocenter Study.

Who this might be right for
Hodgkin Lymphoma
Federico II University 32
Testing effectiveness (Phase 2)Looking for participantsNCT06190067
What this trial is testing

Azacitidine Plus PD-1 Therapy for R/R Hodgkin Lymphoma

Who this might be right for
Relapsed Classic Hodgkin LymphomaRefractory Classic Hodgkin Lymphoma
Navy General Hospital, Beijing 40
Early research (Phase 1)Looking for participantsNCT05362773
What this trial is testing

MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Leukemia, Acute MyeloidMyelodysplastic SyndromesClassical Hodgkin Lymphoma+5 more
MacroGenics 130
Large-scale testing (Phase 3)WithdrawnNCT05711628
What this trial is testing

A Trial Comparing Chemotherapy Versus Novel Immune Checkpoint Inhibitor (Pembrolizumab) Plus Chemotherapy in Treating Relapsed/Refractory Classical Hodgkin Lymphoma

Who this might be right for
Recurrent Classic Hodgkin LymphomaRefractory Classic Hodgkin Lymphoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT06201507
What this trial is testing

BV-AVD-R Treatment Children Hodgkin's Lymphoma

Who this might be right for
Hodgkin Lymphoma
Beijing Children's Hospital 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT03712202
What this trial is testing

Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma

Who this might be right for
Ann Arbor Stage I Hodgkin LymphomaAnn Arbor Stage I Mixed Cellularity Classic Hodgkin LymphomaAnn Arbor Stage I Nodular Sclerosis Classic Hodgkin Lymphoma+11 more
City of Hope Medical Center 155
Testing effectiveness (Phase 2)Looking for participantsNCT03681561
What this trial is testing

Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Veronika Bachanova 54
Testing effectiveness (Phase 2)Looking for participantsNCT05896046
What this trial is testing

SHR1701 Alone or in Combination With SHR2554 in Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Relapsed or Refractory Hodgkin Lymphoma
Chinese PLA General Hospital 100
Not applicableUnknownNCT04237233
What this trial is testing

Intense Monitoring Study on Tyvyt

Who this might be right for
Relapsed or Refractory Classical Hodgkin's Lymphoma
Innovent Biologics (Suzhou) Co. Ltd. 300
Not applicableLooking for participantsNCT05705531
What this trial is testing

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

Who this might be right for
Cardiovascular DisorderClassic Hodgkin LymphomaClonal Hematopoiesis
Children's Oncology Group 190
Testing effectiveness (Phase 2)Study completedNCT00369681
What this trial is testing

Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma

Who this might be right for
Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 51
Testing effectiveness (Phase 2)Looking for participantsNCT05723055
What this trial is testing

Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University of Utah 9
Large-scale testing (Phase 3)Study completedNCT00129090
What this trial is testing

Mega-CHOEP: Conventional Chemo Vs HD Chemo Followed by Auto SCT in Younger Pts With Aggressive Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)
German High-Grade Non-Hodgkin's Lymphoma Study Group 450
Load More Results